Journal
METABOLIC BRAIN DISEASE
Volume 30, Issue 4, Pages 895-901Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11011-015-9665-1
Keywords
Multiple sclerosis; Insulin resistance; Glucose metabolism; Inflammation; Adipokines; Autonomic dysfunction
Categories
Funding
- Slovak Research and Development Agency [APVV-0028-10]
Ask authors/readers for more resources
There are limited data regarding glucose metabolism dysregulation in multiple sclerosis (MS). Present study investigates glucose and insulin response during oral glucose tolerance test (oGTT) in MS patients. We examined 19 MS patients and 19 age, sex and body mass index (BMI) matched healthy controls. MS patients were newly diagnosed, untreated and with low Expanded Disability Status Scale (EDSS) score (1.1 +/- 0.7). Plasma glucose, lactate, insulin and GLP-1 during oGTT, and fasting adipokines, lipid and inflammatory parameters were analyzed. Insulin sensitivity indices (ISI) were calculated. MS patients had comparable fasting (5.2 +/- 0.3 vs. 5.0 +/- 0.4 mmol/l, p = 0.05) and post-load glucose concentrations as controls. Insulin response to oral glucose load in MS was increased (p = 0.022). Insulin sensitivity was lower in MS compared to controls [ISI(Matsuda) 6.95 +/- 3.44 vs. 10.60 +/- 4.81, p = 0.011 and ISI(Cederholm) 49.9 +/- 15.3 vs. 61.3 +/- 16.3, p = 0.032]. We did not find any difference in lactate, GLP-1, total, HDL and LDL cholesterol, triglycerides, interleukin 6, tumor necrosis factor, C-reactive protein, resistin, leptin, adiponectin levels between groups. We found decreased insulin sensitivity with postprandial hyperinsulinemia in MS patients, which seems not to be related to chronic inflammation or physical inactivity. The role of hyperinsulinemia in CNS function impairment should be further investigated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available